Mia Søgaard's Contact Details

Mia Søgaard's Company Details

ViroGates

N/A, N/A, DK • 20 - 49 Employees
BioTech/Drugs

We improve patient outcomes by empowering healthcare professionals to make better informed clinical decisions, leading to more efficient patient triage. The suPAR biomarker predicts negative patient outcomes across diseases by measuring the immune system's activation level. suPARnostic® is a reliable prognostic tool that enables healthcare professionals to make quick and informed patient triaging decisions at hospital emergency departments.suPARnostic® empowers healthcare professionals to lead patient triage with confidence by making better informed decisions across diseases, backed by reliable biological data. Implementing suPAR in clinical care saves critical resources and valuable time, and results in vastly reduced healthcare costs, more efficient triage, and better patient outcomes. At hospital emergency departments, suPAR delivers faster and safer patient discharges, reduces readmissions, avoids unnecessary admissions, and lowers hospital length of stay.Seamlessly implemented by clinician and laboratory technicians, suPARnostic products fit existing workflows in hospitals, are approved for all the major clinical chemistry analyzers, and delivers results in less than 20 minutes.